ENLUXTRA HELPS HEAL DIABETIC WOUNDS FASTER
ENLUXTRA Smart Self-Adaptive Dressing is the first and only self-regulating superabsorbent fiber dressing with adaptive absorbency and built-in adaptive hydration function. The dressing utilises patented smart polymers for sensing the underlying tissue conditions and adapting local functions accordingly, in order to reliably maintain sustainable moist healing environment and gently cleanse a wound when needed.
Enluxtra is already adopted by leading hospitals such as UCSF Medical Center, San Francisco General Hospital and San Francisco VA, Baylor Health, as well as many other health systems throughout the US.
Enluxtra has been proven successful on more than 100,000 of the most complex, "train wreck" wounds of various etiologies, drainage levels and types, including diabetic ulcers, pressure injuries, post-operative wounds with complications, radiation burns, as well as many others.
Enluxtra has been proven successful on more than 100,000 of the most complex, "train wreck" wounds of various etiologies, drainage levels and types, including diabetic ulcers, pressure injuries, post-operative wounds with complications, radiation burns, as well as many others.
For diabetic foot patients, Enluxtra clinical studies show outstanding results.
Case study: Diabetic foot ulcer secondary to gout
A 60-year-old female presented with a diabetic foot ulcer secondary to gout and neuropathy on the lateral side of her right foot great toe. Patient is morbidly obese with an existing diabetic plantar ulcer of 7 months’ duration. Patient comorbidities include type 2 diabetes mellitus, gout, arthritis, venous insufficiency, hypertension, neuropathy, and Charcot foot disease.
Upon presentation to the clinic, the wound was copiously draining, and inflammation extended to the periwound areas. The periwound skin was erythematous, edematous and warm to the touch.
Read the full study...
Upon presentation to the clinic, the wound was copiously draining, and inflammation extended to the periwound areas. The periwound skin was erythematous, edematous and warm to the touch.
Read the full study...
WEEK 0
Wound secondary to gout at initial presentation, following debridement. Edges were undermined, edematous, and erythematous. Wound was copiously draining.Dressing changes were ordered once daily and performed by a family member. |
WEEK 1
One week after initial application of Enluxtra: drainage drastically reduced and the periwound erythema largely resolved. Wound margins and undermining reduced, and debridement of devitalized tissue revealed exposed tendon. |
WEEK 2
The wound 100% granulated, including over tendon, with no edema or drainage. Periwound redness was no longer present, Wound and peri-wound area remained optimally moist. |
WEEK 8
The wound fully re-epithelialized and the dressings were discontinued. |
Case study: Diabetic amputation and connected plantar ulcer on 66 y.o Patient
A 66-year-old diabetic male with coronary artery disease, renal disease and partially amputated right 3rd toe undergoes amputation of the right 2nd metatarsal head and toe. Patient has past medical history of osteomyelitis in 2nd metatarsal head and proximal phalanx, as well as non-healing tunneling diabetic ulcer on the plantar surface of right foot for 3 months.
Plantar ulcer was packed with iodoform lint-free gauze. ENLUXTRA Self-Adaptive dressing was used over the packed ulcer as well as post amputation over entire incision line.
Read the full study...
Read the full study...
|
NEW!
click on picture to learn more |
|
WHY DOES ENLUXTRA WORK SO WELL FOR DIABETIC WOUNDS?
Diabetes makes healing process much more sensitive to deviations from ideal healing conditions.
Enluxtra makes healing easier by continuously adapting the dressing's function to every part of the wound individually, down to every square millimeter.
Enluxtra makes healing easier by continuously adapting the dressing's function to every part of the wound individually, down to every square millimeter.
Unlike any other type of dressing, Enluxtra addresses every emerging problem instantly, long before it becomes a major complication.
Enluxtra is the only dressing that controls what is going on in the wound and adjusts its properties on the fly:
1. If parts of the wound are exuding large amounts of fluid, Enluxtra absorbs and retains the fluid inside itself, preventing maceration.
2. At the same time, if any part of the wound becomes too dry, Enluxtra is able to provide moisture exactly to that part, preventing desiccation.
3. Sustainable moist wound environment, created by Enluxtra, supports effective natural autolysis of non-viable tissues. Autolytic process is gentle and selective, it affects ONLY non-viable tissues while they are present in a wound, and STOPS when the wound becomes clean, so viable tissues are protected.
4. Unlike any other dressing, Enluxtra is able to effectively evacuate microorganisms, disintegrated biofilms, and liquefied components of slough and necrotic tissue, as well as other pro-inflammatory components, from the wound. This fast non-traumatic natural cleansing process stops chronic inflammation and accelerates wound healing.
The wound under Enluxtra quickly becomes clean, and stays clean.
Studies show that Enluxtra effectively addresses the multiple healing impeding factors (maceration, desiccation, growth of microorganisms, accumulation of dead tissue) and creates favorable conditions for fast healing. Along with proper wound offloading and blood sugar control, Enluxtra is able to accelerate the healing process for diabetic wounds.
1. If parts of the wound are exuding large amounts of fluid, Enluxtra absorbs and retains the fluid inside itself, preventing maceration.
2. At the same time, if any part of the wound becomes too dry, Enluxtra is able to provide moisture exactly to that part, preventing desiccation.
3. Sustainable moist wound environment, created by Enluxtra, supports effective natural autolysis of non-viable tissues. Autolytic process is gentle and selective, it affects ONLY non-viable tissues while they are present in a wound, and STOPS when the wound becomes clean, so viable tissues are protected.
4. Unlike any other dressing, Enluxtra is able to effectively evacuate microorganisms, disintegrated biofilms, and liquefied components of slough and necrotic tissue, as well as other pro-inflammatory components, from the wound. This fast non-traumatic natural cleansing process stops chronic inflammation and accelerates wound healing.
The wound under Enluxtra quickly becomes clean, and stays clean.
Studies show that Enluxtra effectively addresses the multiple healing impeding factors (maceration, desiccation, growth of microorganisms, accumulation of dead tissue) and creates favorable conditions for fast healing. Along with proper wound offloading and blood sugar control, Enluxtra is able to accelerate the healing process for diabetic wounds.
!
Sustainable and balanced moist healing environment, together with continuous non-traumatic natural wound cleansing, help reduce chronic inflammation and accelerate wound healing process.
Sustainable and balanced moist healing environment, together with continuous non-traumatic natural wound cleansing, help reduce chronic inflammation and accelerate wound healing process.
Click on the video below to see how the process works:
|
|
|
ENLUXTRA is covered under Medicare Part B:
HCPCS A6196 for 4”x4”
HCPCS A6197 for 6”x6”
Under the trade name:
Enluxtra Humifiber Wound Dressing (as "other gelling fibers" category)
Covered for exuding wounds, up to 30 dressings per month.
HCPCS A6196 for 4”x4”
HCPCS A6197 for 6”x6”
Under the trade name:
Enluxtra Humifiber Wound Dressing (as "other gelling fibers" category)
Covered for exuding wounds, up to 30 dressings per month.
OTHER WOUNDS:
|
|
|
HOW EASY IS IT TO USE ENLUXTRA?
Very easy. There are no multiple products, just one dressing. All you need to do is select the correct size. Nurses, home caregivers and patients alike can teach themselves by referring to our “How to use” instructions.
HOW DANGEROUS ARE DIABETIC WOUNDS?
The statistics are disturbing. The rate of loss of limbs and lives due to diabetic wounds is often compared to that due to war and cancer.
"Every 20 seconds, somewhere in the world, a limb is lost as a consequence of diabetes"
DFCon11, Bakker (after Boulton), DFCon.com
Boulton, The Lancet (cover), Nov. 2005
"Every 20 seconds, somewhere in the world, a limb is lost as a consequence of diabetes"
DFCon11, Bakker (after Boulton), DFCon.com
Boulton, The Lancet (cover), Nov. 2005
BUT IT IS ONLY A SCRATCH!
Ulcers never just appear, they all start as insignificant breaks in skin. It’s the deadly combination of the above reasons that quickly turns a small wound into a non-healing ulcer. If an early stage diabetic wound is not treated timely and properly, the patient risks amputation and even death.
WHY DO DIABETIC WOUNDS DEVELOP?
There are two reasons why diabetic wounds develop and go unnoticed until it’s too late.
First, the narrowed blood vessels reduce the circulation and tissue nourishment in legs and feet.
Second, high blood sugar level damages the nerves resulting in reduced sensation.
First, the narrowed blood vessels reduce the circulation and tissue nourishment in legs and feet.
Second, high blood sugar level damages the nerves resulting in reduced sensation.
WHAT TO DO??
The importance of early treatment of diabetic wounds cannot be stressed enough. If a small wound is healed before it develops into a late stage ulcer, the patient has a much greater chance of avoiding complications that may lead to amputation, or death.
